Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennie H Best

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Seminars in Arthritis and Rheumatism|September 27, 2017
Effectiveness of biologic and non-biologic antirheumatic drugs on anaemia markers in 153,788 patients with rheumatoid arthritis: New evidence from real-world dataSanjoy Ketan Paul, Olga Montvida, Jennie H Best, et al.
The American Journal of Managed Care|October 9, 2012
Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimensJennie H Best, John A Romley, Dana P Goldman, et al.
The Journal of Rheumatology|January 17, 2018
Association Between Glucocorticoid Exposure and Healthcare Expenditures for Potential Glucocorticoid-related Adverse Events in Patients with Rheumatoid ArthritisJennie H Best, Amanda M Kong, Gregory M Lenhart, et al.
Health and Quality of Life Outcomes|October 9, 2012
Development and validation of the self-management profile for type 2 diabetes (SMP-T2D)Mark Peyrot, Donald M Bushnell, Jennie H Best, et al.
Infectious Diseases and Therapy|March 14, 2024
Household Influenza Transmission and Healthcare Resource Utilization Among Patients Treated with Baloxavir vs Oseltamivir: A United States Outpatient Prospective SurveyJennie H Best, Mitra Sadeghi, Xiaowu Sun, et al.
Journal of Medical Economics|March 26, 2010
The economic value of reducing medication dosing frequency with drug delivery technologies: an evidence assessmentMindy M Cheng, Rafael Alfonso, Jennie H Best, et al.
Plos One|January 6, 2023
Mechanical ventilation for COVID-19: Outcomes following discharge from inpatient treatmentMark J Butler, Jennie H Best, Shalini V Mohan, et al.
Journal of Medical Economics|February 29, 2012
Long-term cost-consequence analysis of exenatide once weekly vs sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United StatesAnne-Laure Guillermin, Adam Lloyd, Jennie H Best, et al.
Diabetes Care|January 29, 2011
Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatmentJennie H Best, Richard R Rubin, Mark Peyrot, et al.
Journal of Medical Economics|January 31, 2024
Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antiviralsJennie H Best, Sheila R Reddy, Eunice Chang, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Seminars in Arthritis and Rheumatism|September 27, 2017
Effectiveness of biologic and non-biologic antirheumatic drugs on anaemia markers in 153,788 patients with rheumatoid arthritis: New evidence from real-world dataSanjoy Ketan Paul, Olga Montvida, Jennie H Best, et al.
The American Journal of Managed Care|October 9, 2012
Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimensJennie H Best, John A Romley, Dana P Goldman, et al.
The Journal of Rheumatology|January 17, 2018
Association Between Glucocorticoid Exposure and Healthcare Expenditures for Potential Glucocorticoid-related Adverse Events in Patients with Rheumatoid ArthritisJennie H Best, Amanda M Kong, Gregory M Lenhart, et al.
Health and Quality of Life Outcomes|October 9, 2012
Development and validation of the self-management profile for type 2 diabetes (SMP-T2D)Mark Peyrot, Donald M Bushnell, Jennie H Best, et al.
Infectious Diseases and Therapy|March 14, 2024
Household Influenza Transmission and Healthcare Resource Utilization Among Patients Treated with Baloxavir vs Oseltamivir: A United States Outpatient Prospective SurveyJennie H Best, Mitra Sadeghi, Xiaowu Sun, et al.
Journal of Medical Economics|March 26, 2010
The economic value of reducing medication dosing frequency with drug delivery technologies: an evidence assessmentMindy M Cheng, Rafael Alfonso, Jennie H Best, et al.
Plos One|January 6, 2023
Mechanical ventilation for COVID-19: Outcomes following discharge from inpatient treatmentMark J Butler, Jennie H Best, Shalini V Mohan, et al.
Journal of Medical Economics|February 29, 2012
Long-term cost-consequence analysis of exenatide once weekly vs sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United StatesAnne-Laure Guillermin, Adam Lloyd, Jennie H Best, et al.
Diabetes Care|January 29, 2011
Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatmentJennie H Best, Richard R Rubin, Mark Peyrot, et al.
Journal of Medical Economics|January 31, 2024
Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antiviralsJennie H Best, Sheila R Reddy, Eunice Chang, et al.
Pageof 4